Adam B. Weiner, MD, and Ruchika Talwar, MD, discuss some of the notable urologic oncology abstracts that were presented at the 2023 AUA meeting.
In this episode of Speaking of Urology®, Adam B. Weiner, MD, and Ruchika Talwar, MD, discuss some of the notable urologic oncology abstracts that were presented at the 2023 American Urological Association Annual meeting, which was held April 28-May 1 in Chicago, Illinois. Weiner is a urologic oncology fellow at the University of California, Los Angeles, and Talwar is a urologic oncology fellow at Vanderbilt University in Nashville, Tennessee.
This recap was originally presented by Dr. Weiner and Dr. Talwar during a live Twitter Spaces event held by Urology Times. In the discussion, Weiner and Talwar touch on the followed abstracts:
Don’t forget to subscribe to Speaking of Urology® on Spotify, Apple Podcasts, or anywhere that podcasts are available.
Blue light cystoscopy decreases risk of recurrence, progression in NMIBC
May 9th 2024“The results of the BRAVO study performed within the VA health care system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a BLC compared to patients who received WLC only,” says Stephen B. Williams, MD, MBA, MS, FACS, FACHE.